Submitted by Anonymous (not verified) on 13 September 2023 - 12:35
Human medicines European public assessment report (EPAR): Tandemact, pioglitazone,glimepiride, Diabetes Mellitus, Type 2, Date of authorisation: 08/01/2007, Revision: 22, Status: Authorised
Source: